CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021 2021 – NOT current data.
Posts Tagged
‘adverse’
Illustration by Laurène Boglio Hello and welcome to this week’s community newsletter! I am your host, Chelsey B. Coombs, the engagement editor of Spectrum. The first paper to grab Twitter’s attention praised a transdiagnostic approach to neurodevelopmental disorders such as autism and attention deficit hyperactivity disorder. Clinicians typically diagnose these disorders using the criteria in […]